Before COVID-19,
Norman Sharples ran a company that was a market leader in a very niche business — supplying nasal swabs collection kits for detecting respiratory viruses such as the flu.
Obviously, that all changed with the pandemic. Demand for nasal swabs and the media that keep samples viable on their way to diagnostic labs blew up to unheard of levels.
Sharples, chief executive of COPAN Diagnostics in Murrieta, knew he needed more manufacturing capacity in the U.S. But he questioned whether he could get a factory up and running soon enough to make a significant impact.
.
That’s when Apple reached out to Sharples. The iPhone maker offered $10 million from its Advanced Manufacturing Fund, as well as engineering and sourcing expertise.